BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28287323)

  • 1. Relationship Between the Comprehensive Nutritional Index and the EORTC QLQ-H&N35 in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy.
    He Y; Chen L; Chen L; Hu W; Wang C; Tang L; Mai H; Li J; Wu L; Fan Y
    Nutr Cancer; 2017 Apr; 69(3):436-443. PubMed ID: 28287323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
    Deng J; He Y; Sun XS; Li JM; Xin MZ; Li WQ; Li ZX; Nie S; Wang C; Li YZ; Chen LP; Chen LM; Zhu SH; Li JW; Hu W; Fan YY; Guo SS; Mai HQ
    Oral Oncol; 2019 Nov; 98():62-68. PubMed ID: 31541928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
    Bian X; Song T; Wu S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between the comprehensive nutrition index and quality of life of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
    Ma L; Wu T; Pan J; Kong X; Guo Q; Yang L; Zhang Y; Lin S; Chen C; Huang C
    Nutr Cancer; 2014; 66(1):152-8. PubMed ID: 24328938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
    Guo SS; Hu W; Chen QY; Li JM; Zhu SH; He Y; Li JW; Xia L; Ji L; Lin CY; Liu LT; Tang LQ; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Fan YY; Mai HQ
    BMC Cancer; 2018 Jan; 18(1):114. PubMed ID: 29386004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
    Chen J; Liu P; Wang Q; Wu L; Zhang X
    Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.
    McMillan AS; Pow EH; Kwong DL; Wong MC; Sham JS; Leung LH; Leung WK
    Head Neck; 2006 Aug; 28(8):712-22. PubMed ID: 16475203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Poon DMC; Kam MKM; Johnson D; Mo F; Tong M; Chan ATC
    Head Neck; 2021 Jun; 43(6):1711-1720. PubMed ID: 33576030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified-Nutrition Index is a Significant Prognostic Factor for the Overall Survival of the Nasopharyngeal Carcinoma Patients who Undergo Intensity-modulated Radiotherapy.
    Hong JS; Hua YJ; Su L; Zhang HR; Lv WL; Chen XY; Tian J; Zhang WJ
    Nutr Cancer; 2017 Oct; 69(7):1011-1018. PubMed ID: 28937797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
    Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of life expectancy and quality-adjusted life expectancy in non-metastatic nasopharyngeal cancer patients treated by intensity-modulated radiotherapy with or without chemotherapy.
    Lai CH; Chen MF; Fang FM; Chen WC
    Oral Oncol; 2014 Jul; 50(7):646-50. PubMed ID: 24747031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
    Zhao C; Chen J; Yu B; Chen X
    Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
    Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
    Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
    Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.